Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another thought...
The revenue percentage would increase but that does not necessarily mean that the revenue would increase. Smaller companies that TPL contacts may pay 20-30 % royalty but if their revenues are lower than that of agilent then the amount tpl/ptsc gets may not be higher that 9 mil but could actually be lower.
Share
New Message
Please login to post a reply